120 related articles for article (PubMed ID: 12140486)
1. Granulocyte and monocyte adsorption apheresis for pyoderma gangrenosum.
Kanekura T; Maruyama I; Kanzaki T
J Am Acad Dermatol; 2002 Aug; 47(2):320-1. PubMed ID: 12140486
[No Abstract] [Full Text] [Related]
2. Successful treatment of pyoderma gangrenosum with granulocyte and monocyte adsorption apheresis.
Russo I; Miotto S; Colpo A; Marson P; Tison T; Ferrazzi A; Alaibac M
Int Wound J; 2017 Feb; 14(1):282-284. PubMed ID: 27790848
[TBL] [Abstract][Full Text] [Related]
3. Leukocyte adsorption apheresis for the treatment of pyoderma gangrenosum.
Watanabe Y; Yamada H
J Dermatol; 2008 Dec; 35(12):792-4. PubMed ID: 19239562
[No Abstract] [Full Text] [Related]
4. Pyoderma Gangrenosum with Ulcerative Colitis Successfully Treated by the Combination of Granulocyte and Monocyte Adsorption Apheresis and Corticosteroids.
Ohno M; Koyama S; Ohara M; Shimamoto K; Kobayashi Y; Nakamura F; Mitsuru K; Andoh A
Intern Med; 2016; 55(1):25-30. PubMed ID: 26726081
[TBL] [Abstract][Full Text] [Related]
5. Treatment of pyoderma gangrenosum with granulocyte and monocyte adsorption apheresis.
Kanekura T; Kawahara K; Maruyama I; Kanzaki T
Ther Apher Dial; 2005 Aug; 9(4):292-6. PubMed ID: 16076369
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of granulocyte and monocyte adsorption apheresis for three cases of refractory pyoderma gangrenosum.
Seishima M; Mizutani Y; Shibuya Y; Nagasawa C; Aoki T
Ther Apher Dial; 2007 Jun; 11(3):177-82. PubMed ID: 17497998
[TBL] [Abstract][Full Text] [Related]
7. Pyoderma Gangrenosum, Acne and Suppurative Hidradenitis Syndrome Treated with Granulocyte and Monocyte Adsorption Apheresis.
Mizutani Y; Okano T; Takahashi T; Ohnishi H; Ohara O; Sano A; Seishima M
Acta Derm Venereol; 2017 Feb; 97(2):275-276. PubMed ID: 27384061
[No Abstract] [Full Text] [Related]
8. Successful treatment of pyoderma gangrenosum, acne, and suppurative hidradenitis syndrome with granulocyte and monocyte adsorption apheresis.
Hatanaka M; Fujii K; Kanekura T
J Dermatol; 2021 Aug; 48(8):e376-e377. PubMed ID: 33991008
[No Abstract] [Full Text] [Related]
9. Reduction of interleukin-6, interleukin-8, and anti-phosphatidylserine-prothrombin complex antibody by granulocyte and monocyte adsorption apheresis in a patient with pyoderma gangrenosum and ulcerative colitis.
Kawakami T; Yamazaki M; Soma Y
Am J Gastroenterol; 2009 Sep; 104(9):2363-4. PubMed ID: 19727102
[No Abstract] [Full Text] [Related]
10. Leukocytapheresis treatment for pyoderma gangrenosum.
Fujimoto E; Fujimoto N; Kuroda K; Tajima S
Br J Dermatol; 2004 Nov; 151(5):1090-2. PubMed ID: 15541092
[TBL] [Abstract][Full Text] [Related]
11. A case report of steroid and immunosuppressant-resistant pyoderma gangrenosum successfully treated by granulocytapheresis.
Okuma K; Mitsuishi K; Hasegawa T; Tsuchihashi H; Ogawa H; Ikeda S
Ther Apher Dial; 2007 Oct; 11(5):387-90. PubMed ID: 17845399
[TBL] [Abstract][Full Text] [Related]
12. Clinical implications of leukocytapheresis using a centrifugal cell separator for steroid-resistant pyoderma gangrenosum associated with inflammatory bowel disease.
Hanafusa T; Azukizawa H; Umegaki N; Tani M; Yamaguchi Y; Katayama I
J Dermatol; 2011 May; 38(5):507-10. PubMed ID: 21352279
[No Abstract] [Full Text] [Related]
13. Therapy Insight: pyoderma gangrenosum-old disease, new management.
Campbell S; Cripps S; Jewell DP
Nat Clin Pract Gastroenterol Hepatol; 2005 Dec; 2(12):587-94. PubMed ID: 16327838
[TBL] [Abstract][Full Text] [Related]
14. Beneficial effects of neutrophil-targeted therapy for pyoderma gangrenosum associated with ulcerative colitis.
Ikeda K; Hamada T; Otsuka M; Iwatsuki K
Eur J Dermatol; 2011; 21(5):804-5. PubMed ID: 21752760
[No Abstract] [Full Text] [Related]
15. Pyoderma gangrenosum in myelodysplasia responding to granulocyte macrophage-colony stimulating factor (GM-CSF).
Bulvik S; Jacobs P
Br J Dermatol; 1997 Apr; 136(4):637-8. PubMed ID: 9155982
[No Abstract] [Full Text] [Related]
16. Pyoderma gangrenosum coexisting with acute myelogenous leukaemia.
Krauze E; Brzezińska-Wcisło L; Kamińska-Winciorek G; Wygledowska-Kania M; Sygula E
J Eur Acad Dermatol Venereol; 2005 Sep; 19(5):589-92. PubMed ID: 16164714
[TBL] [Abstract][Full Text] [Related]
17. Portable negative-pressure wound therapy for pyoderma gangrenosum: Report of two cases.
Yamaguchi Y; Yanagi T; Sato K; Yoshimoto N; Hirata Y; Ujiie I; Nishimura M; Natsuga K; Shiiya C; Tsukinaga I; Shimizu H
J Dermatol; 2018 Apr; 45(4):483-486. PubMed ID: 29235669
[TBL] [Abstract][Full Text] [Related]
18. Peristomal pyoderma gangrenosum (PG): A simple hydrocolloid dressing technique to promote wound healing.
Rodenbeck DL; Kennon AW; Davis LS
J Am Acad Dermatol; 2015 Sep; 73(3):e107-8. PubMed ID: 26282808
[No Abstract] [Full Text] [Related]
19. Evaluation of the efficacy of granulocyte and monocyte adsorption apheresis on skin manifestation and joint symptoms of patients with pustulotic arthro-osteitis.
Kawakami H; Nagaoka Y; Hirano H; Matsumoto Y; Abe N; Tsuboi R; Kanno Y; Okubo Y
J Dermatol; 2019 Feb; 46(2):144-148. PubMed ID: 30549087
[TBL] [Abstract][Full Text] [Related]
20. Pyoderma gangrenosum: A clinico-epidemiological study.
Riyaz N; Mary V; Sasidharanpillai S; Roshin RA; Snigdha O; Latheef EN; Rahima S; Bindu V; Anupama RN; Sureshan DN; Sherjeena PV
Indian J Dermatol Venereol Leprol; 2017; 83(1):33-39. PubMed ID: 27549869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
